54916-27-7

Basic information

• Product Name: 1-(4-(4-BROMOPHENOXY)PHENYL)ETHANONE
• Synonyms: 1-(4-(4-BROMOPHENOXY)PHENYL)ETHANONE;SALOR-INT L499366-1EA
• CAS NO: 54916-27-7
• Molecular Formula: C₁₄H₁₁BrO₂
• Molecular Weight: 291.14
• Mol File: 54916-27-7.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 377.977 °C at 760 mmHg
• Flash Point: 182.394 °C
• Appearance: /
• Density: 1.401 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.593
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(4-(4-BROMOPHENOXY)PHENYL)ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-(4-BROMOPHENOXY)PHENYL)ETHANONE(54916-27-7)
• EPA Substance Registry System: 1-(4-(4-BROMOPHENOXY)PHENYL)ETHANONE(54916-27-7)

Safety Data

• Hazardous Substances Data: 54916-27-7(Hazardous Substances Data)

Usage

General Description

1-(4-(4-Bromophenoxy)phenyl)ethanone is a chemical compound that belongs to the family of ketones. It is a white crystalline solid with the molecular formula C16H13BrO2 and a molecular weight of 315.18 g/mol. 1-(4-(4-BROMOPHENOXY)PHENYL)ETHANONE is used in organic synthesis and pharmaceutical research as a building block for the synthesis of various biologically active compounds. It is a versatile and important intermediate in the production of pharmaceuticals, agrochemicals, and other fine chemicals. The bromine atom in its structure makes it a versatile compound for further derivatization and modification, allowing for the development of new drugs and chemical compounds through synthetic pathways.

InChI:InChI=1/C14H11BrO2/c1-10(16)11-2-6-13(7-3-11)17-14-8-4-12(15)5-9-14/h2-9H,1H3

Upstream product

• 5031-78-7 4-phenoxyacetophenone 
• 106-41-2 4-bromo-phenol 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 5467-74-3 4-Bromophenylboronic acid 
• 100-19-6 (4-nitrophenyl)ethanone 
• 149104-90-5 4-acetylphenylboronic acid 
• 403-41-8 1-(4-Fluorophenyl)ethanol 

Downstream Products

• 717909-77-8 2-bromo-1-(4-(4-bromophenoxy)phenyl)ethanone 
• 38110-18-8 (E)-3-[4-(4-Bromo-phenoxy)-phenyl]-but-2-enoic acid methyl ester 
• 20185-64-2 4-(4-bromophenoxy)phenyl acetate 
• 38110-20-2 (E)-3-[4-(4-Bromo-phenoxy)-phenyl]-but-2-enoic acid diethylamide 
• 852631-08-4 [4-(4-bromophenoxy)phenyl]acetic acid 
• 852631-10-8 [4-(4-bromophenoxy)phenyl]acetic acid methyl ester 
• 852631-15-3 [4-(4-bromophenoxy)phenyl]malonic acid dimethyl ester 
• 852631-19-7 5-[4-(4-bromophenoxy)phenyl]barbituric acid 
• 852631-23-3 5-(4-(4-bromophenoxy)phenyl)-2-thioxodihydropyrimidine-4,6-dione 
• 852631-24-4 5-bromo-5-[4-(4-bromophenoxy)phenyl]pyrimidine-2,4,6-trione 
• 852631-28-8 5-bromo-5-[4-(4-bromophenoxy)phenyl]-2-thioxodihydropyrimidine-4,6-dione 
• 681287-20-7 5-[4-(4-bromo-phenoxy)-phenyl]-5-piperazin-1-yl-pyrimidine-2,4,6-trione 
• 393796-64-0 5-[4-(4-bromo-phenoxy)-phenyl]-5-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-pyrimidine-2,4,6-trione 
• 681287-35-4 5-[4-(4-bromo-phenoxy)-phenyl]-5-[4-(4-trimethylsilanyl-phenyl)-piperazin-1-yl]-pyrimidine-2,4,6-trione 

Relevant articles and documents

Exploring Tandem Ruthenium-Catalyzed Hydrogen Transfer and SNAr Chemistry

A hydrogen-transfer strategy for the catalytic functionalization of benzylic alcohols via electronic arene activation, accessing a diverse range of bespoke diaryl ethers and aryl amines in excellent isolated yields (38 examples, 70% average yield), is reported. Taking advantage of the hydrogen-transfer approach, the oxidation level of the functionalized products can be selected by judicious choice of simple and inexpensive additives.

Ligand-free copper-catalyzed O-arylation of nitroarenes with phenols

The first example of ligand-free copper-catalyzed O-arylation of nitroarenes with phenols was developed, achieving unsymmetrical diaryl ethers in moderate to excellent yields. This arylation proceeded smoothly without promotion of the ligands, and displayed great functional group compatibility. Thus, the method represents a new, facile, and cost-effective approach to access unsymmetrical diaryl ethers.

Amino-pyridines as inhibitors of beta-secretase

The present invention provides an amino-pyridine compound of formula I The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.